Literature DB >> 1505579

Salla disease variant in a Dutch patient. Potential value of polymorphonuclear leucocytes for heterozygote detection.

G M Mancini1, P Hu, F W Verheijen, O P van Diggelen, H C Janse, W J Kleijer, F A Beemer, F G Jennekens.   

Abstract

A Dutch child with psychomotor retardation, impaired speech, ataxia, sialic acid storage and vacuolized skin fibroblasts and lymphocytes was diagnosed as having free sialic acid storage disease. Slight corneal opacities, pale optic disks at the fundus oculi and vertebral abnormalities, not earlier reported in Salla disease, were peculiar to this case. Free sialic acid was about tenfold increased in urine and cultured fibroblasts, without changes in the glycoconjugate-bound sialic acid pool. A subsequent pregnancy of the patient's mother was monitored by assay of sialic acid in chorionic villi and amniotic fluid. An unaffected foetus was predicted. Sialic acid was also assayed in peripheral blood total leucocytes, and in mononuclear and polymorphonuclear (PMN) leucocyte subpopulations. Each of these leucocyte fractions from the patient showed 10- to 30-fold increase in sialic acid content. The PMN subpopulation provided the most restricted range of control values and showed slightly increased values for the patient's parents. These results suggest that the assay of sialic acid in PMN might be useful for the identification of heterozygotes in sialic acid storage disease. Studies on a larger number of obligate heterozygotes are needed to confirm this observation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505579     DOI: 10.1007/bf01957729

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  34 in total

1.  Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin.

Authors:  D Roos; J A Loos
Journal:  Biochim Biophys Acta       Date:  1970-12-29

2.  Determination of sialic acid using 2-thiobarbituric acid in the absence of hazardous sodium arsenite.

Authors:  P C Denny; P A Denny; S E Allerton
Journal:  Clin Chim Acta       Date:  1983-07-15       Impact factor: 3.786

3.  A thin layer chromatographic technique for screening for sialuria.

Authors:  J C Michalski; J Montreuil; G Strecker
Journal:  Clin Chim Acta       Date:  1983-03-28       Impact factor: 3.786

4.  Sialic acid storage diseases. A multiple lysosomal transport defect for acidic monosaccharides.

Authors:  G M Mancini; C E Beerens; P P Aula; F W Verheijen
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Clinical and laboratory diagnosis of Salla disease in infancy and childhood.

Authors:  M Renlund
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

6.  Sialic acid storage disease with sialuria: clinical and biochemical features in the severe infantile type.

Authors:  R E Stevenson; M Lubinsky; H A Taylor; D A Wenger; R J Schroer; P M Olmstead
Journal:  Pediatrics       Date:  1983-10       Impact factor: 7.124

7.  Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein.

Authors:  F W Verheijen; S Palmeri; A T Hoogeveen; H Galjaard
Journal:  Eur J Biochem       Date:  1985-06-03

8.  Generalized N-acetylneuraminic acid storage disease: quantitation and identification of the monosaccharide accumulating in brain and other tissues.

Authors:  L W Hancock; M M Thaler; A L Horwitz; G Dawson
Journal:  J Neurochem       Date:  1982-03       Impact factor: 5.372

Review 9.  Sialic acid storage disorders: observations on clinical and biochemical variation.

Authors:  G M Mancini; F W Verheijen; C E Beerens; M Renlund; P Aula
Journal:  Dev Neurosci       Date:  1991       Impact factor: 2.984

10.  Infantile sialic acid storage disease: the fate of biosynthetically labeled N-acetyl-(3H)-neuraminic acid in cultured human fibroblasts.

Authors:  E Paschke; G Höfler; A Roscher
Journal:  Pediatr Res       Date:  1986-08       Impact factor: 3.756

View more
  7 in total

1.  The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation.

Authors:  N Aula; P Salomäki; R Timonen; F Verheijen; G Mancini; J E Månsson; P Aula; L Peltonen
Journal:  Am J Hum Genet       Date:  2000-08-17       Impact factor: 11.025

Review 2.  Lysosomal transport disorders.

Authors:  G M Mancini; A C Havelaar; F W Verheijen
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

3.  Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.

Authors:  J L Keulemans; A J Reuser; M A Kroos; R Willemsen; M M Hermans; A M van den Ouweland; J G de Jong; R A Wevers; W O Renier; D Schindler; M J Coll; A Chabas; H Sakuraba; Y Suzuki; O P van Diggelen
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

4.  Lysosomal free sialic acid storage disorders with different phenotypic presentations--infantile-form sialic acid storage disease and Salla disease--represent allelic disorders on 6q14-15.

Authors:  J Schleutker; P Leppänen; J E Månsson; A Erikson; J Weissenbach; L Peltonen; P Aula
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

5.  Prenatal screening of sialic acid storage disease and confirmation in cultured fibroblasts by LC-MS/MS.

Authors:  Jeroen van den Bosch; Linda F Oemardien; Malgorzata I Srebniak; Monique Piraud; Jan G M Huijmans; Frans W Verheijen; George J G Ruijter
Journal:  J Inherit Metab Dis       Date:  2011-05-27       Impact factor: 4.982

6.  Identification of a large intronic transposal insertion in SLC17A5 causing sialic acid storage disease.

Authors:  Maja Tarailo-Graovac; Britt I Drögemöller; Wyeth W Wasserman; Colin J D Ross; Ans M W van den Ouweland; Niklas Darin; Gittan Kollberg; Clara D M van Karnebeek; Maria Blomqvist
Journal:  Orphanet J Rare Dis       Date:  2017-02-10       Impact factor: 4.123

7.  Homozygosity for the p.K136E mutation in the SLC17A5 gene as cause of an Italian severe Salla disease.

Authors:  R Biancheri; A Rossi; H A Verbeek; R Schot; F Corsolini; S Assereto; G M S Mancini; F W Verheijen; C Minetti; M Filocamo
Journal:  Neurogenetics       Date:  2005-09-17       Impact factor: 2.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.